Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Asset Utilization Ratio (2024 - 2025)

Historic Asset Utilization Ratio for Krystal Biotech (KRYS) over the last 4 years, with Q3 2025 value amounting to 0.31.

  • Krystal Biotech's Asset Utilization Ratio rose 2338.68% to 0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31, marking a year-over-year increase of 2338.68%. This contributed to the annual value of 0.31 for FY2024, which is 32093.86% up from last year.
  • Krystal Biotech's Asset Utilization Ratio amounted to 0.31 in Q3 2025, which was up 2338.68% from 0.32 recorded in Q2 2025.
  • Over the past 5 years, Krystal Biotech's Asset Utilization Ratio peaked at 0.32 during Q2 2025, and registered a low of 0.0 during Q4 2021.
  • Its 4-year average for Asset Utilization Ratio is 0.19, with a median of 0.22 in 2024.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first soared by 209108.55% in 2024, then soared by 2338.68% in 2025.
  • Krystal Biotech's Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then surged by 2375.81% to 0.06 in 2023, then soared by 352.34% to 0.29 in 2024, then grew by 10.05% to 0.31 in 2025.
  • Its last three reported values are 0.31 in Q3 2025, 0.32 for Q2 2025, and 0.31 during Q1 2025.